Alnylam Pharmaceuticals, Inc.
USD286.12
-9.51 (-3.22%)
CEO
Yvonne L. Greenstreet
IPO Date
2004-06-01
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$293.94
Prev. Close
$295.63
Day Low
$285.00
Day High
$295.60
52W Low
$284.28
52W High
$495.55
Market Cap
$38.20B
Volume
1.04M
| 1,441 |
| $298.48 |
| 22 May 2026 | SCHULMAN AMY W | director | A-Award | Acquired | 838 | $0.00 |
| 22 May 2026 | SCHULMAN AMY W | director | A-Award | Acquired | 1,802 | $298.48 |
| 22 May 2026 | Reitan Colleen F | director | A-Award | Acquired | 671 | $0.00 |
| 22 May 2026 | Reitan Colleen F | director | A-Award | Acquired | 1,441 | $298.48 |
| 22 May 2026 | PYOTT DAVID E I | director | A-Award | Acquired | 671 | $0.00 |
| 22 May 2026 | PYOTT DAVID E I | director | A-Award | Acquired | 1,441 | $298.48 |
| 22 May 2026 | KELLOGG PETER N | director | A-Award | Acquired | 671 | $0.00 |
| 22 May 2026 | KELLOGG PETER N | director | A-Award | Acquired | 1,441 | $298.48 |
| $1,001 - $15,000 |
| 7 Jan 2024 | Josh Gottheimer | Josh Gottheimer | Sale | $1,001 - $15,000 |
| 17 Apr 2023 | Daniel Goldman | Daniel Goldman | Purchase | $15,001 - $50,000 |
| 8 Mar 2023 | Ro Khanna | Ro Khanna | Sale | $1,001 - $15,000 |
| 24 Feb 2023 | Daniel Goldman | Daniel Goldman | Sale | $15,001 - $50,000 |
| 3 Jan 2023 | Ro Khanna | Ro Khanna | Purchase | $1,001 - $15,000 |
| 16 Oct 2022 | Josh Gottheimer | Josh Gottheimer | Purchase | $1,001 - $15,000 |
| 9 Dec 2020 | Josh Gottheimer | Josh Gottheimer | Sale (Full) | $1,001 - $15,000 |